SCHEMBL8470

SCHEMBL8470

ClC1=Nc2ccccc2Sc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.47
BACE1 P56817 1/20 0.45
LMNA P02545 3/20 0.43
CHRM2 P08172 2/20 0.43
HTR1A P08908 2/20 0.43
ADRA2A P08913 2/20 0.43
CHRM1 P11229 2/20 0.43
ADRA2B P18089 2/20 0.43
ADRA2C P18825 2/20 0.43
CHRM3 P20309 2/20 0.43
DRD1 P21728 2/20 0.43
HTR2A P28223 2/20 0.43
HTR2C P28335 2/20 0.43
ADRA1A P35348 2/20 0.43
HRH1 P35367 2/20 0.43
OPRM1 P35372 2/20 0.43
DRD3 P35462 2/20 0.43
HTR2B P41595 2/20 0.43
KCNH2 Q12809 2/20 0.43
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5344836 0.94 DRD2 (0.44) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL4672786 0.84 HRH4 (0.58) DRD2LMNACHRM2HTR1AADRA2A
SCHEMBL31098228 0.84 DRD2 (0.58) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL1568889 0.83 DRD2 (0.56) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL11505754 0.82 TRPA1 (0.41) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL8251675 0.81 HRH4 (0.46) DRD2LMNACHRM2HTR1AADRA2A
SCHEMBL21761445 0.81 ALDH1A1 (0.46) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL5057241 0.81 HRH4 (0.43) DRD2LMNACHRM2HTR1AADRA2A
SCHEMBL11559842 0.79 ALDH1A1 (0.43) DRD2BACE1LMNACHRM2HTR1A
SCHEMBL20036412 0.78 DRD2 (0.36) DRD2BACE1LMNACHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120136813-A Deuterium-labeled quetiapine fumarate isotope compound, preparation method thereof and food detection method 曼哈格(上海)生物科技有限公司 2025-06-13 CN claimed
US-8389716-B2 Process for the synthesis of quetiapine F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2013-03-05 US claimed
US-8048876-B2 Process for preparing quetiapine and quetiapine fumarate MEDICHEM S.A. (ES) 2011-11-01 US claimed
US-20110118460-A1 PROCESS FOR THE SYNTHESIS OF QUETIAPINE F.I.S. FABBRICA ITALIANA SINTETICI S.P.A (IT) 2011-05-19 US claimed
US-20090076262-A1 PROCESS FOR PREPARING QUETIAPINE AND QUETIAPINE FUMARATE MEDICHEM, S.A. (ES) 2009-03-19 US claimed
WO-2008152434-A1 SYNTHESIS FOR THE PREPARATION OF QUETIAPINE RICHTER GEDEON NYRT. (HU) 2008-12-18 WO claimed
WO-2006135544-A1 SYNTHESIS OF 11-(4[-(2-HYDROXYETHOXY)ETHYL]-PIPERAZINYL)-DIBENZO[b,f][1,4]THIAZEPINE AND ITS FUMARATE SALT CAMBREX CHARLES CITY, INC. (US) 2006-12-21 WO claimed
US-20060276641-A1 Process for preparing quetiapine fumarate TEVA PHARMACEUTICAL INDUSTRIES LTD (IL) 2006-12-07 US claimed
US-20060063927-A1 Processes for preparing quetiapine and salts thereof CHEMAGIS LTD. (IL) 2006-03-23 US claimed
CN-120136813-A Deuterium-labeled quetiapine fumarate isotope compound, preparation method thereof and food detection method 曼哈格(上海)生物科技有限公司 2025-06-13 CN disclosed
CN-120136813-A Deuterium-labeled quetiapine fumarate isotope compound, preparation method thereof and food detection method 曼哈格(上海)生物科技有限公司 2025-06-13 CN disclosed
CN-114181172-B Efficient preparation method of quetiapine fumarate 浙江苏泊尔制药有限公司 2023-12-22 CN disclosed
CN-114671829-B Heterodiad taking indenone and dibenzoazepine as parent nucleus and hydrochloride thereof, preparation method and application thereof 合肥工业大学 2023-07-25 CN disclosed
CN-114181172-A Efficient preparation method of quetiapine fumarate 浙江苏泊尔制药有限公司 2022-03-15 CN disclosed
EP-1602650-A1 Method for the preparation of quetiapine by reductive N-alkylation of 11-Piperazinodibenzo(B,F) (1,4)Thioazepin with an aldehyde Celon Pharma Sp. z o.o. (PL) 2005-12-07 EP disclosed
EP-0282236-B1 PROCESS FOR THE PREPARATION OF A THIAZEPINE COMPOUND IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-12-11 EP disclosed
EP-0240228-B1 THIAZEPINE COMPOUNDS ICI AMERICAS INC. (US) 1990-11-07 EP disclosed
US-4879288-A Novel dibenzothiazepine antipsychotic ICI AMERICAS INC. (US) 1989-11-07 US disclosed
EP-0282236-A1 Process for the preparation of a thiazepine compound IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-09-14 EP disclosed
EP-0240228-A1 Thiazepine compounds ICI AMERICAS INC. (US) 1987-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063927-A1 Processes for preparing quetiapine and salts thereof CYP3A5, QDPR, CYP4Z1 DRD2 33/4885BACE1 416/4885LMNA 3978/4885
US-20060276641-A1 Process for preparing quetiapine fumarate SDHA, SDHB, FH DRD2 626/4885BACE1 674/4885LMNA 1329/4885
US-20110118460-A1 PROCESS FOR THE SYNTHESIS OF QUETIAPINE CYP4F11, MAOB, CYP2F1 DRD2 216/4885BACE1 566/4885LMNA 3750/4885
US-20090076262-A1 PROCESS FOR PREPARING QUETIAPINE AND QUETIAPINE FUMARATE CYP2F1, FH, FAH DRD2 616/4885BACE1 898/4885LMNA 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.